Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Drogasil is a leading Brazilian retail pharmacy chain and a flagship brand of the RD Saúde group, formerly known as RaiaDrogasil. Established in 1935, the company has grown into one of the most recognizable healthcare brands in South America, operating thousands of stores across all Brazilian states. Drogasil provides a comprehensive range of prescription medications, over-the-counter drugs, hygiene products, and beauty supplies. Beyond retail, the company offers integrated healthcare services including vaccinations, laboratory tests, and pharmaceutical consultations through its Saúde em Dia program. As part of the RD Saúde ecosystem, Drogasil leverages advanced digital platforms and a robust loyalty program to enhance patient care and wellness. The company is a key player in the Brazilian healthcare infrastructure, focusing on accessibility and specialized pharmaceutical support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Drogasil.